Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 10 studies | 22% ± 9% | |
epithelial cell | 3 studies | 20% ± 2% | |
GABAergic neuron | 3 studies | 22% ± 4% | |
endothelial cell of artery | 3 studies | 16% ± 1% |
Insufficient scRNA-seq data for expression of TAOK2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 8576.79 | 258 / 258 | 100% | 43.99 | 230 / 230 |
esophagus | 100% | 5425.80 | 1445 / 1445 | 100% | 28.04 | 183 / 183 |
intestine | 100% | 5594.09 | 966 / 966 | 100% | 24.19 | 527 / 527 |
prostate | 100% | 6236.52 | 245 / 245 | 100% | 30.31 | 502 / 502 |
skin | 100% | 4919.66 | 1809 / 1809 | 100% | 33.85 | 472 / 472 |
thymus | 100% | 7063.01 | 653 / 653 | 100% | 31.71 | 605 / 605 |
uterus | 100% | 7385.42 | 170 / 170 | 100% | 30.01 | 459 / 459 |
breast | 100% | 7917.00 | 459 / 459 | 100% | 35.75 | 1117 / 1118 |
brain | 100% | 6416.39 | 2640 / 2642 | 100% | 46.20 | 704 / 705 |
lung | 100% | 8817.23 | 578 / 578 | 100% | 26.31 | 1152 / 1155 |
kidney | 100% | 5222.92 | 89 / 89 | 100% | 32.08 | 898 / 901 |
ovary | 100% | 5924.76 | 180 / 180 | 99% | 20.74 | 427 / 430 |
bladder | 100% | 5517.76 | 21 / 21 | 99% | 27.42 | 500 / 504 |
stomach | 100% | 4405.37 | 359 / 359 | 99% | 25.80 | 283 / 286 |
pancreas | 99% | 2800.24 | 326 / 328 | 99% | 29.06 | 177 / 178 |
liver | 100% | 2381.42 | 225 / 226 | 99% | 17.66 | 403 / 406 |
adipose | 100% | 7638.68 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 31.26 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 22.13 | 29 / 29 |
spleen | 100% | 9072.17 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 27.82 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 16.39 | 1 / 1 |
heart | 100% | 4355.30 | 860 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 4532.78 | 1333 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 3028.73 | 799 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 92% | 2867.26 | 855 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0032956 | Biological process | regulation of actin cytoskeleton organization |
GO_0032874 | Biological process | positive regulation of stress-activated MAPK cascade |
GO_0001558 | Biological process | regulation of cell growth |
GO_0046330 | Biological process | positive regulation of JNK cascade |
GO_0006974 | Biological process | DNA damage response |
GO_0150020 | Biological process | basal dendrite arborization |
GO_0043410 | Biological process | positive regulation of MAPK cascade |
GO_0006612 | Biological process | protein targeting to membrane |
GO_0007409 | Biological process | axonogenesis |
GO_0051403 | Biological process | stress-activated MAPK cascade |
GO_0007095 | Biological process | mitotic G2 DNA damage checkpoint signaling |
GO_0032147 | Biological process | activation of protein kinase activity |
GO_0030036 | Biological process | actin cytoskeleton organization |
GO_0048041 | Biological process | focal adhesion assembly |
GO_0006915 | Biological process | apoptotic process |
GO_0031954 | Biological process | positive regulation of protein autophosphorylation |
GO_0008360 | Biological process | regulation of cell shape |
GO_0006468 | Biological process | protein phosphorylation |
GO_0046777 | Biological process | protein autophosphorylation |
GO_0150019 | Biological process | basal dendrite morphogenesis |
GO_0016477 | Biological process | cell migration |
GO_0005730 | Cellular component | nucleolus |
GO_0043235 | Cellular component | receptor complex |
GO_0031410 | Cellular component | cytoplasmic vesicle |
GO_0005654 | Cellular component | nucleoplasm |
GO_0043005 | Cellular component | neuron projection |
GO_0015629 | Cellular component | actin cytoskeleton |
GO_0005829 | Cellular component | cytosol |
GO_0044294 | Cellular component | dendritic growth cone |
GO_0044295 | Cellular component | axonal growth cone |
GO_0005737 | Cellular component | cytoplasm |
GO_0030424 | Cellular component | axon |
GO_0030659 | Cellular component | cytoplasmic vesicle membrane |
GO_0031434 | Molecular function | mitogen-activated protein kinase kinase binding |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0043539 | Molecular function | protein serine/threonine kinase activator activity |
GO_0004709 | Molecular function | MAP kinase kinase kinase activity |
GO_0050321 | Molecular function | tau-protein kinase activity |
GO_0005524 | Molecular function | ATP binding |
GO_0048156 | Molecular function | tau protein binding |
GO_0005515 | Molecular function | protein binding |
GO_0038191 | Molecular function | neuropilin binding |
Gene name | TAOK2 |
Protein name | Serine/threonine-protein kinase TAO2 (EC 2.7.11.1) (Kinase from chicken homolog C) (hKFC-C) (Prostate-derived sterile 20-like kinase 1) (PSK-1) (PSK1) (Prostate-derived STE20-like kinase 1) (Thousand and one amino acid protein kinase 2) non-specific serine/threonine protein kinase (EC 2.7.11.1) |
Synonyms | PSK PSK1 MAP3K17 KIAA0881 UNQ2971/PRO7431 |
Description | FUNCTION: Serine/threonine-protein kinase involved in different processes such as membrane blebbing and apoptotic bodies formation DNA damage response and MAPK14/p38 MAPK stress-activated MAPK cascade. Phosphorylates itself, MBP, activated MAPK8, MAP2K3, MAP2K6 and tubulins. Activates the MAPK14/p38 MAPK signaling pathway through the specific activation and phosphorylation of the upstream MAP2K3 and MAP2K6 kinases. In response to DNA damage, involved in the G2/M transition DNA damage checkpoint by activating the p38/MAPK14 stress-activated MAPK cascade, probably by mediating phosphorylation of upstream MAP2K3 and MAP2K6 kinases. Isoform 1, but not isoform 2, plays a role in apoptotic morphological changes, including cell contraction, membrane blebbing and apoptotic bodies formation. This function, which requires the activation of MAPK8/JNK and nuclear localization of C-terminally truncated isoform 1, may be linked to the mitochondrial CASP9-associated death pathway. Isoform 1 binds to microtubules and affects their organization and stability independently of its kinase activity. Prevents MAP3K7-mediated activation of CHUK, and thus NF-kappa-B activation, but not that of MAPK8/JNK. May play a role in the osmotic stress-MAPK8 pathway. Isoform 2, but not isoform 1, is required for PCDH8 endocytosis. Following homophilic interactions between PCDH8 extracellular domains, isoform 2 phosphorylates and activates MAPK14/p38 MAPK which in turn phosphorylates isoform 2. This process leads to PCDH8 endocytosis and CDH2 cointernalization. Both isoforms are involved in MAPK14 phosphorylation. . |
Accessions | ENST00000543033.5 [Q9UL54-4] Q6PIN8 A0PJ48 ENST00000279394.7 [Q9UL54-2] Q9UL54 ENST00000416441.2 [Q9UL54-3] ENST00000308893.9 [Q9UL54-1] Q86V37 |